Skip to main content
RLAY filings

Corporate insider profile

Thomas Catinazzo Filing Activity

Latest reported as Chief Financial Officer of Relay Therapeutics, Inc. (RLAY).

Purchase filings
0
Reported companies
1
Net open-market value
-$3,419,083.83
Latest transaction
Jun 22, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jun 22, 2026Relay Therapeutics, Inc. (RLAY)Chief Financial OfficerSale187,163$16.97$3,176,867
May 14, 2026Relay Therapeutics, Inc. (RLAY)Chief Financial OfficerSale17,717$12.86$227,841
Apr 28, 2026Relay Therapeutics, Inc. (RLAY)Chief Financial OfficerSale972$14.79$14,376